International Journal of Nephrology [25] Y. Okada, X. J. Zuo, A. M. Marchevsky et al., “Antithrombin III treatment improves parameters of acute inﬂammation in a highly histoincompatible model of rat lung allograft rejection,” Transplantation, vol. 67, no. 4, pp. 526–528, 1999. [26] R. N. Puglisi, L. Strande, M. Santos, G. Schulte, C. W. Hewitt, and T. V. Whalen, “Beneﬁcial eﬀects of cyclosporine and rapamycin in small bowel ischemic injury,” Journal of Surgical Research, vol. 65, no. 2, pp. 115–118, 1996. [27] J. Sharkey and S. P. Butcher, “Immunophilins mediate the neuroprotective eﬀects of FK506 in focal cerebral ischaemia,” Nature, vol. 371, no. 6495, pp. 336–339, 1994. [28] N. Varda-Bloom, J. Leor, D. G. Ohad et al., “Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 12, pp. 2141– 2149, 2000. [29] P. Boros and J. S. Bromberg, “New cellular and molecular immune pathways in ischemia/reperfusion injury,” American Journal of Transplantation, vol. 6, no. 4, pp. 652–658, 2006. [30] H. Rabb, F. Daniels, M. O’Donnell et al., “Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice,” American Journal of Physiology, vol. 279, no. 3, pp. F525–F531, 2000. [31] M. J. Burne, F. Daniels, A. El Ghandour et al., “Identiﬁcation of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure,” Journal of Clinical Investigation, vol. 108, no. 9, pp. 1283–1290, 2001. [32] N. Yokota, M. Burne-Taney, L. Racusen, and H. Rabb, “Con- trasting roles for STAT4 and STAT6 signal transduction path- ways in murine renal ischemia-reperfusion injury,” American Journal of Physiology, vol. 285, no. 2, pp. F319–F325, 2003. [33] M. L. Lie, R. J. Santora, H. Rabb, and H. T. Hassoun, “Distant organ T Cell traﬃcking and activation during Ischemic Acute Kidney Injury (AKI),” Journal of Surgical Research, vol. 158, p. 291, 2010. [34] D. B. Ascon, S. Lopez-Briones, M. Liu et al., “Phenotypic and functional characterization of kidney-inﬁltrating lymphocytes in renal ischemia reperfusion injury,” Journal of Immunology, vol. 177, no. 5, pp. 3380–3387, 2006. [35] K. Hochegger, T. Scha¨tz, P. Eller et al., “Role of α/β and γ/δ T cells in renal ischemia-reperfusion injury,” American Journal of Physiology, vol. 293, no. 3, pp. F741–F747, 2007. [36] S. R. Satpute, J. M. Park, H. R. Jang et al., “The role for T cell repertoire/antigen-speciﬁc interactions in experimental kidney ischemia reperfusion injury,” Journal of Immunology, vol. 183, no. 2, pp. 984–992, 2009. [37] M. Ascon, D. B. Ascon, M. Liu et al., “Renal ischemia- reperfusion leads to long term inﬁltration of activated and eﬀector-memory T lymphocytes,” Kidney International, vol. 75, no. 5, pp. 526–535, 2009. [38] M. J. Burne-Taney, M. Liu, D. Ascon, R. R. Molls, L. Racusen, and H. Rabb, “Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease?” American Journal of Physiology, vol. 291, no. 5, pp. F981–F986, 2006. [39] M. J. Burne-Taney, D. B. Ascon, F. Daniels, L. Racusen, W. Baldwin, and H. Rabb, “B cell deﬁciency confers protection from renal ischemia reperfusion injury,” Journal of Immunol- ogy, vol. 171, no. 6, pp. 3210–3215, 2003. [40] R. L. Mehta, M. T. Pascual, C. G. Gruta, S. Zhuang, and G. M. Chertow, “Reﬁning predictive models in critically ill patients with acute renal failure,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1350–1357, 2002. 7 [41] Z. Ricci and C. Ronco, “Pulmonary/renal interaction,” Current Opinion in Critical Care, vol. 16, no. 1, pp. 13–18, 2010. [42] G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American- European Consensus Conference on ARDS: deﬁnitions, mech- anisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 818–824, 1994. [43] A. A. Kramer, G. Postler, K. F. Salhab, C. Mendez, L. C. Carey, and H. Rabb, “Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular perme- ability,” Kidney International, vol. 55, no. 6, pp. 2362–2367, 1999. [44] H. Rabb, Z. Wang, T. Nemoto, J. Hotchkiss, N. Yokota, and M. Soleimani, “Acute renal failure leads to dysregulation of lung salt and water channels,” Kidney International, vol. 63, no. 2, pp. 600–606, 2003. [45] C. L. Klein, T. S. Hoke, W. F. Fang, C. J. Altmann, I. S. Douglas, and S. Faubel, “Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy,” Kidney International, vol. 74, no. 7, pp. 901–909, 2008. [46] T. S. Hoke, I. S. Douglas, C. L. Klein et al., “Acute renal fail- ure after bilateral nephrectomy is associated with cytokine- mediated pulmonary injury,” Journal of the American Society of Nephrology, vol. 18, no. 1, pp. 155–164, 2007. [47] D. J. Kim, S. H. Park, M. R. Sheen et al., “Comparison of experimental lung injury from acute renal failure with injury due to sepsis,” Respiration, vol. 73, no. 6, pp. 815–824, 2006. [48] D. N. Grigoryev, M. Liu, H. T. Hassoun, C. Cheadle, K. C. Barnes, and H. Rabb, “The local and systemic inﬂammatory transcriptome after acute kidney injury,” Journal of the Ameri- can Society of Nephrology, vol. 19, no. 3, pp. 547–558, 2008. [49] A. Zarbock, M. Schmolke, T. Spieker, K. Jurk, H. Van Aken, and K. Singbartl, “Acute uremia but not renal inﬂammation attenuates aseptic acute lung injury: a critical role for uremic neutrophils,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3124–3131, 2006. [50] G. Matute-Bello, W. C. Liles, F. Radella II et al., “Neutrophil apoptosis in the acute respiratory distress syndrome,” Ameri- can Journal of Respiratory and Critical Care Medicine, vol. 156, no. 6, pp. 1969–1977, 1997. [51] G. Matute-Bello, W. C. Liles, K. P. Steinberg et al., “Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS),” Journal of Immunology, vol. 163, no. 4, pp. 2217–2225, 1999. [52] A. Q. Raﬁ, A. Zeytun, M. J. Bradley et al., “Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome,” Journal of Immunology, vol. 161, no. 6, pp. 3077–3086, 1998. [53] S. M. Dudek and J. G. N. Garcia, “Cytoskeletal regulation of pulmonary vascular permeability,” Journal of Applied Physiol- ogy, vol. 91, no. 4, pp. 1487–1500, 2001. [54] H. T. Hassoun, M. L. Lie, D. N. Grigoryev, M. Liu, R. M. Tuder, and H. Rabb, “Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis,” American Journal of Physiology, vol. 297, no. 1, pp. F125–F137, 2009. [55] P. Blake, Y. Hasegawa, M. C. Khosla, F. Fouad-Tarazi, N. Sakura, and E. P. Paganini, “Isolation of “myocardial depres- sant factor(s)” from the ultraﬁltrate of heart failure patients with acute renal failure,” ASAIO Journal, vol. 42, no. 5, pp. M911–M915, 1996. [56] K. J. Kelly, “Distant eﬀects of experimental renal ischemia/ reperfusion injury,” Journal of the American Society of Nephrol- ogy, vol. 14, no. 6, pp. 1549–1558, 2003.